Muscle and Joint Vanishing Scent

Description

The product is identified by the SPL code 34089-3. No specific description details are provided in the text.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains of muscles and joints associated with simple backache, arthritis, and sprains.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children aged 2 years and older should apply the gel generously to the affected area and gently massage until the gel is fully absorbed. This application may be repeated up to 3 to 4 times daily, depending on the severity of the condition. For optimal results, it is recommended to squeeze the tube from the bottom and flatten it as the product is used.

For children under 2 years of age, it is advised to consult a physician prior to use.

Contraindications

Use is contraindicated in situations where there is a risk of accidental poisoning, particularly in children. It is essential to keep this product away from children to prevent potential harm. No other contraindications have been identified.

Warnings and Precautions

For external use only. This product is contraindicated for use with heating pads, as this may lead to increased risk of adverse effects. It is imperative to keep this product out of reach of children to prevent accidental poisoning.

When applying the product, care should be taken to avoid tight bandaging, as this may exacerbate potential side effects. The product is not intended for ingestion; if swallowed, it is crucial to induce vomiting and seek immediate medical attention.

Users should avoid contact with eyes and mucous membranes, as exposure may result in irritation. Additionally, the product should not be applied to wounds or any broken, damaged, or irritated skin.

In the event that the condition worsens, or if skin redness, irritation, or pain persists for more than 7 days, it is advised to discontinue use and consult a physician. For children under 12 years of age with arthritis-like conditions, the product should not be used, and a physician should be contacted for appropriate guidance.

Side Effects

Patients using this product should be aware of several important warnings and precautions. This product is intended for external use only and should not be used in conjunction with a heating pad. It is crucial to keep the product out of reach of children to prevent accidental poisoning. Patients are advised against tightly bandaging the area of application and should not swallow the product. In the event of ingestion, it is recommended to induce vomiting and seek medical attention immediately.

Care should be taken to avoid contact with the eyes and mucous membranes. The product should not be applied to wounds or broken, damaged, or irritated skin. If patients experience worsening of their condition, development of skin redness or irritation, or if pain persists for more than 7 days, they should discontinue use and consult a physician. Additionally, for children under 12 years of age with arthritis-like conditions, the product should not be used, and medical advice should be sought.

Drug Interactions

The use of this medication is contraindicated with heating pads, as the combination may lead to adverse effects. It is essential to avoid this interaction to ensure patient safety.

No specific drug or laboratory test interactions have been identified. Therefore, routine monitoring for interactions with other medications or laboratory tests is not necessary.

Packaging & NDC

Below are the non-prescription pack sizes of Muscle and Joint Vanishing Scent (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be closely monitored to prevent accidental poisoning; the product must be kept away from children. For children under 12 years of age with arthritis-like conditions, the product is not recommended, and a physician should be consulted.

For children aged 2 years and older, the product can be applied generously and gently massaged into the affected area until the gel disappears, with a maximum frequency of 3 to 4 times daily. In children under 2 years of age, consultation with a physician is advised prior to use.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

There is currently no information available regarding the use of this drug during pregnancy, including safety concerns, dosage modifications, or any special precautions that should be taken. Healthcare professionals are advised to consider the lack of data when prescribing this medication to pregnant patients and to weigh the potential risks and benefits. Women of childbearing potential should be counseled on the absence of information related to pregnancy and encouraged to discuss any concerns with their healthcare provider.

Lactation

There are no specific warnings or recommendations regarding the use of this product by nursing mothers. Additionally, there are no statements concerning the potential for excretion in breast milk or any associated risks to breastfed infants during lactation.

Renal Impairment

There is no specific information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, immediate action is crucial. If the substance is ingested, it is recommended to induce vomiting as a first response. Following this, it is imperative to contact a physician for further evaluation and management.

Healthcare professionals should be aware of the potential symptoms that may arise from an overdosage, although specific symptoms are not detailed in the provided information. The management of overdosage should be guided by clinical judgment and may involve supportive care and symptomatic treatment as necessary.

Prompt medical intervention is essential to mitigate any adverse effects associated with overdosage. Therefore, healthcare providers are advised to remain vigilant and prepared to act swiftly in such situations.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental poisoning. It is essential to emphasize the importance of proper storage and handling to ensure the safety of young children. Patients should be informed about the potential risks associated with accidental ingestion and encouraged to take necessary precautions.

Storage and Handling

The product is supplied in various configurations, with specific NDC numbers available for identification. It should be stored at a temperature range of 15°C to 30°C (59°F to 86°F) to maintain its efficacy and safety.

For proper handling, it is essential to check the Lot Number and Expiration Date, which can be found on the box or the crimp of the tube. This ensures that the product is used within its designated shelf life and maintains its intended quality.

Additional Clinical Information

The product is intended for topical administration, with application recommended to be generous and accompanied by gentle massage until the gel is fully absorbed. Patients may repeat this process up to 3 to 4 times daily.

Clinicians should counsel patients on important safety precautions: the product is for external use only and should not be used in conjunction with heating pads. It must be kept out of reach of children to prevent accidental poisoning, and should not be tightly bandaged or swallowed. In the event of ingestion, patients should induce vomiting and seek medical attention. Care should be taken to avoid contact with eyes and mucous membranes, and the product should not be applied to wounds or broken, damaged, or irritated skin. If the condition worsens, if skin redness or irritation occurs, or if pain persists beyond 7 days, patients should discontinue use and consult a physician. Additionally, the product is not recommended for use in children under 12 for arthritis-like conditions; a physician should be contacted in such cases.

Drug Information (PDF)

This file contains official product information for Muscle and Joint Vanishing Scent, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)